3/11
09:48 am
lgvn
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease [Yahoo! Finance]
Medium
Report
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease [Yahoo! Finance]
3/11
08:30 am
lgvn
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
Medium
Report
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
3/5
09:25 am
lgvn
Longeveron® to Present at the 37th Annual Roth Conference
Medium
Report
Longeveron® to Present at the 37th Annual Roth Conference
3/3
08:10 am
lgvn
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
High
Report
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/2
07:37 am
lgvn
Analysts Expect Breakeven For Longeveron Inc. (NASDAQ:LGVN) Before Long [Yahoo! Finance]
High
Report
Analysts Expect Breakeven For Longeveron Inc. (NASDAQ:LGVN) Before Long [Yahoo! Finance]
2/28
06:44 pm
lgvn
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
2/28
04:04 pm
lgvn
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
Medium
Report
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
2/21
08:30 am
lgvn
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
Low
Report
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
2/18
10:42 am
lgvn
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™ [Yahoo! Finance]
Low
Report
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™ [Yahoo! Finance]
2/18
09:25 am
lgvn
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
Medium
Report
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
2/14
09:05 am
lgvn
Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025
Medium
Report
Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025
12/18
09:22 am
lgvn
Longeveron to Present at Biotech Showcase 2025 [Yahoo! Finance]
Medium
Report
Longeveron to Present at Biotech Showcase 2025 [Yahoo! Finance]
12/18
09:10 am
lgvn
Longeveron to Present at Biotech Showcase 2025
Medium
Report
Longeveron to Present at Biotech Showcase 2025